50% clinical remission is pretty good, considering
Post# of 72433
![Avatar](/images/ProfileImages/398685088_3064_306524.png)
The bar isn't set very high for approval. J&J's Remicade, the leader in the UC market with $2B in annual sales, had 39% of patients with clinical remission comparing to 15% in the placebo group.
http://www.remicadehcp.com/ulcerative-colitis...-remission
Then there are the side effects of biologics.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
![Dont-give-up.jpg](https://styleshack.com/wp-content/uploads/2014/07/Dont-give-up.jpg)